Ads attract fewer warning letters

Share this article:
Warning and untitled letters on broadcast and print DTC ads have plummeted since PhRMA's adoption of its Guiding Principles on DTC in August 2005.

In 2004, the FDA's Division of Drug Marketing, Advertising and Communications issued 13 warning and untitled letters on DTC ads. From January to August of 2005, the agency issued 17 warning and untitled letters on DTC ads. Since then, it has issued two—neither of which concerns broadcast or print, the media covered by PhRMA's voluntary code. “It reflects a significant change in attitude at DDMAC,” said John Kamp, executive director of the Coalition for Healthcare Communications.  

Share this article:

Email Newsletters

More in News

Sanofi tightens PCSK9 race, exceeds Q2 expectations

Sanofi tightens PCSK9 race, exceeds Q2 expectations

Sanofi and partner Regeneron attached a $67.5-million priority review voucher to their experimental cholesterol drug alirocumab, making for a tighter race with Amgen.

HHS shows how diabetes adds up

HHS shows how diabetes adds up

A 2005-to-2010 survey shows diabetics 65-and-up juggle at least four co-morbid conditions and five medications for them.

AstraZenca beefs up respiratory portfolio

AstraZenca beefs up respiratory portfolio

AstraZeneca has made an $875-million move to beef up its respiratory pipeline by making Almirall's lineup its own.